Notify me when University Of Texas/Texas Am Investment Management Co files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RNTX | Aileron Therapeutics, Inc. | Common Stock, par value $0.001 per share | 4.4% | $1.76M | 961K | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | Nov 4, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|